Science
Neuroscience Microbiology Cell Biology Genetics Immunology Virology Molecular Biology Human Biology Physiology Cancer Biology
The deal gives Lilly a preclinical Tethosome non‑viral DNA delivery platform, a lipid‑nanoparticle approach designed to target potency, tolerability and re‑dosing limits in DNA therapies.